Marc Puigvehi

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study.

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study.

Journal: BMC public health

Published: December 18, 2023

Reply to: 'Abnormal liver function tests and coronavirus disease 2019: A close relationship'.

Reply to: 'Abnormal liver function tests and coronavirus disease 2019: A close relationship'.

Journal: Journal of viral hepatitis

Published: October 20, 2022

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.

Journal: Molecular cancer therapeutics

Published: May 11, 2022

Follow-up evaluation of patients with liver test abnormalities detected during SARS-CoV2 infection.

Follow-up evaluation of patients with liver test abnormalities detected during SARS-CoV2 infection.

Journal: Journal of viral hepatitis

Published: March 10, 2022

Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.

Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 28, 2022

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma.

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: December 05, 2021

Prevalence and characteristics of hepatitis C virus-related hepatocellular carcinoma in a Spanish university hospital.

Prevalence and characteristics of hepatitis C virus-related hepatocellular carcinoma in a Spanish university hospital.

Journal: Cancer epidemiology

Published: September 16, 2021

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification.

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification.

Journal: Gut

Published: August 24, 2021

On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty.

On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: August 24, 2021

Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.

Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.

Journal: Gastroenterology

Published: June 07, 2021

Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.

Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: November 25, 2020

Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).

Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).

Journal: Gastroenterology

Published: November 24, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026